These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22654722)

  • 21. Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders.
    Drew PD; Xu J; Storer PD; Chavis JA; Racke MK
    Neurochem Int; 2006 Jul; 49(2):183-9. PubMed ID: 16753239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs.
    Puhl AC; Milton FA; Cvoro A; Sieglaff DH; Campos JC; Bernardes A; Filgueira CS; Lindemann JL; Deng T; Neves FA; Polikarpov I; Webb P
    Nucl Recept Signal; 2015; 13():e004. PubMed ID: 26445566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons.
    Klotz L; Sastre M; Kreutz A; Gavrilyuk V; Klockgether T; Feinstein DL; Heneka MT
    J Neurochem; 2003 Aug; 86(4):907-16. PubMed ID: 12887689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents.
    Kaundal RK; Sharma SS
    Drug News Perspect; 2010 May; 23(4):241-56. PubMed ID: 20520853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin Attenuates Beta-Amyloid-Induced Neuroinflammation via Activation of Peroxisome Proliferator-Activated Receptor-Gamma Function in a Rat Model of Alzheimer's Disease.
    Liu ZJ; Li ZH; Liu L; Tang WX; Wang Y; Dong MR; Xiao C
    Front Pharmacol; 2016; 7():261. PubMed ID: 27594837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis-Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines.
    Fakan B; Szalardy L; Vecsei L
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPAR Regulation of Inflammatory Signaling in CNS Diseases.
    Bright JJ; Kanakasabai S; Chearwae W; Chakraborty S
    PPAR Res; 2008; 2008():658520. PubMed ID: 18670616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications.
    Jiang Q; Heneka M; Landreth GE
    CNS Drugs; 2008; 22(1):1-14. PubMed ID: 18072811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.
    Wang X; Wang Y; Hu JP; Yu S; Li BK; Cui Y; Ren L; Zhang LD
    Mol Neurobiol; 2017 May; 54(4):2939-2949. PubMed ID: 27023226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
    Gasparini L; Ongini E; Wenk G
    J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of PPARs in Disease.
    Wagner N; Wagner KD
    Cells; 2020 Oct; 9(11):. PubMed ID: 33126411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway.
    Cheng Y; Dong Z; Liu S
    Pharmacology; 2014; 94(1-2):1-12. PubMed ID: 25171128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease.
    Landreth GE; Heneka MT
    Neurobiol Aging; 2001; 22(6):937-44. PubMed ID: 11755002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease.
    Heneka MT; Kummer MP; Weggen S; Bulic B; Multhaup G; Münter L; Hüll M; Pflanzner T; Pietrzik CU
    Curr Alzheimer Res; 2011 Mar; 8(2):115-31. PubMed ID: 21345168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.
    Sodhi RK; Singh N; Jaggi AS
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):115-24. PubMed ID: 21607645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.
    Bernardo A; Minghetti L
    PPAR Res; 2008; 2008():864140. PubMed ID: 18464925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [PPARs, metabolic syndrome and cardiac diseases].
    Carvajal K; Hernández-Esquivel Mde L; Moreno-Sánchez R
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-66-76. PubMed ID: 18938701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.
    Yamanaka M; Ishikawa T; Griep A; Axt D; Kummer MP; Heneka MT
    J Neurosci; 2012 Nov; 32(48):17321-31. PubMed ID: 23197723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
    Pasinetti GM
    J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.